Toxicogenomics in risk assessment: an overview of an HESI collaborative research program.

The value of genomic approaches in hypothesis generation is being realized as a tool for understanding toxicity and consequently contributing to an assessment of drug and chemical safety. In 1999 the membership of the International Life Sciences Institute Health and Environmental Sciences Institute formed a committee to develop a collaborative scientific program to address issues, challenges, and opportunities afforded by the emerging field of toxicogenomics. Experts and advisors from academia and government laboratories participate on the committee, along with approximately 30 corporate member organizations from the pharmaceutical, agrochemical, chemical, and consumer products industries. The committee has designed, conducted, and analyzed numerous toxicogenomic experiments within the broad fields of hepatotoxicity, nephrotoxicity, and genotoxicity. The considerable body of data generated by these programs has been instrumental in increasing understanding of sources of biological and technical variability in the alignment of toxicant-induced transcription changes with the accepted mechanism of action of these agents and the challenges in the consistent analysis and sharing of the voluminous data sets generated by these approaches. Recognizing the importance of standardized microarray data formats and public repository databases as the mechanism by which microarray data can be compared and interpreted by the scientific community, the committee has partnered with the European Bioinformatics Institute to develop a database to house the data generated by its collaborative research.

[1]  Sergio Contrino,et al.  ArrayExpress—a public repository for microarray gene expression data at the EBI , 2004, Nucleic Acids Res..

[2]  J. Waring,et al.  Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arrays. , 2004, Environmental health perspectives.

[3]  Alfred Bach,et al.  Transcriptomics in predictive toxicology. , 2002, Current opinion in drug discovery & development.

[4]  K. Morgan.  Gene expression analysis reveals chemical-specific profiles. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  Syril D. Pettit,et al.  Use of Genomics in Mechanism Based Risk Assessment , 2003 .

[6]  R G Ulrich,et al.  Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. , 2001, Toxicology letters.

[7]  J. Waring,et al.  The promise of toxicogenomics. , 2002, Current opinion in molecular therapeutics.

[8]  P. S. Pine,et al.  Dye bias correction in dual-labeled cDNA microarray gene expression measurements. , 2004, Environmental health perspectives.

[9]  Jiri Aubrecht,et al.  The utility of DNA microarrays for characterizing genotoxicity. , 2004, Environmental health perspectives.

[10]  Frank D Sistare,et al.  Identification of platform-independent gene expression markers of cisplatin nephrotoxicity. , 2004, Environmental health perspectives.

[11]  K. Thompson,et al.  Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessment. , 2004, Environmental health perspectives.

[12]  J. Waring,et al.  Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene. , 2004, Environmental health perspectives.

[13]  Stephen H. Friend,et al.  Toxicogenomics and drug discovery: will new technologies help us produce better drugs? , 2002, Nature Reviews Drug Discovery.

[14]  Michael D Waters,et al.  Database development in toxicogenomics: issues and efforts. , 2004, Environmental health perspectives.

[15]  W. Mattes.  Annotation and cross-indexing of array elements on multiple platforms. , 2004, Environmental health perspectives.

[16]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.

[17]  R. Ulrich,et al.  Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression. , 2004, Environmental health perspectives.

[18]  Timothy A Bertram,et al.  Identification of putative gene based markers of renal toxicity. , 2004, Environmental health perspectives.

[19]  J. Trent,et al.  Microarrays and toxicology: The advent of toxicogenomics , 1999, Molecular carcinogenesis.

[20]  R. Dunn,et al.  Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  Quantitative PCR deconstruction of discrepancies between results reported by different hybridization platforms. , 2004, Environmental health perspectives.

[22]  T R Zacharewski,et al.  Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  S W Burchiel,et al.  Analysis of genetic and epigenetic mechanisms of toxicity: potential roles of toxicogenomics and proteomics in toxicology. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  C. Duggan,et al.  The use of genomics technology to investigate gene expression changes in cultured human liver cells. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[25]  L. L. Smith,et al.  Key challenges for toxicologists in the 21st century. , 2001, Trends in pharmacological sciences.

[26]  Christopher J Portier,et al.  Toxicogenomics: the new frontier in risk analysis. , 2002, Carcinogenesis.

[27]  T. Kepler,et al.  Morphologic analysis correlates with gene expression changes in cultured F344 rat mesothelial cells. , 2000, Toxicology and applied pharmacology.

[28]  R. Tennant,et al.  The National Center for Toxicogenomics: using new technologies to inform mechanistic toxicology. , 2002, Environmental health perspectives.